North Brunswick, NJ (PRWEB) October 20, 2007
Biotech Support Group LLC and ProFACT Proteomics Inc., form a strategic alliance to provide consulting services in the field of profiling serum protein for proteomic analysis by using SeraFILE™ a revolutionary new technology in the field of proteomics. Dr. Swapan Roy, President of Biotech Support Group, LLC, says, "SeraFILE™'s revolutionary technology and standards-based protocols will allow Biotech Support Group LLC to expand our business into the proteomics market. With the company's collaboration with Profact Proteomics Inc, Biotech Support Group LLC is well positioned to provide consulting services in the field of profiling serum protein for proteomic analysis. We look forward to working with our new customers."
ProFACT Proteomics Inc has introduced SeraFILE™ -- a proprietary surface library that generates differential protein pools in an automated system, while retaining biological activity. Being amenable to a variety of downstream analyses, SeraFILE™ combines elements of biochemical and functional profiling quantitatively providing a modality that is open-ended and industrially productive with reduced protein complexity. New profiling techniques are now available which generate signatures across a multiplicity of sub-proteomes and interrogations along with a means to characterize enzyme regulation and related functional sub-states from disease.
One example is Dr. Kiran Madura's research involving the Ubiquitin/Proteasome Pathway, which degrades and eliminates unwanted or misformed proteins and is thus essential to cell function. Dr. Madura is the Director of the Program in Biochemistry and Molecular Biology at Robert Wood Johnson Medical School, an affiliate of the University of Medicine and Dentistry of New Jersey. By incorporating SeraFILE™, key elements of this pathway may be revealed. "Our goal is to generate new cancer profiles, and ultimately, new diagnostics and therapeutics down the road," said Dr. Madura.
As nothing is discarded, through pool recombinations, Rational Proteome Prospecting™ techniques can be applied to discover important enzyme regulating factors. SeraFILE™ can be advantageous in common proteomic investigations using 1DE/2DE/Mass Spec, or through ProFACT's proprietary menu of services.
SeraFILE™ enables discovery strategies that enrich catalytic activity and directly couple to drug development thereby leading proteomic researchers to new pre-clinical drug development tools, theranostic protein signatures, and functional biomarkers. Both Biotech Support Group and Profact Proteomics are now actively seeking new customers interested in consulting services for proteomics research using the SeraFILE™ technology. Located in the Technology Center of New Jersey, Biotech Support Group is already helping many regional pharmaceutical and academic institutions with their innovative products. In essence, the company is providing tools which may help to speed the discovery of new therapies in cancer and other devastating diseases.
About Biotech Support Group LLC:
Established in 1995, Biotech Support Group is a privately owned New Jersey based biotechnology company that manufactures and markets proprietary products for genomics and proteomics research. Recently, Biotech Support Group has launched an online media portal for the proteomics community (http://www.biotechsupportgroup.net/proteomics/). The company's DiscoverPrep™ Proteomic Sample Preparation line of products are successfully used by pharmaceutical, university and academic research labs, as well as many institutions in the private and public sector. In 2007, the company has taken measures to enhance it's DiscoverPrep line of products by expanding it's research and development program. In addition to DiscoverPrep™, the company provides HPLC columns for separation of biomaterials. With the company's collaboration with Profact Proteomics Inc, Biotech Support Group LLC is now well positioned to provide consulting services in the field of profiling serum protein for proteomic analysis.